Synthesis and evaluation of novel biaryl oxazolidinones effective against gram-positive bacterial infections

被引：0

作者：

Bhawsar, Satish ^{[1
]}

Shaikh, Mohammad ^{[1
]}

Joshi, Sanjeev ^{[1
]}

Mishra, Amit ^{[1
]}

Pavase, Laxmikant ^{[1
]}

Chavan, Vijay ^{[1
]}

Kale, Amol ^{[1
]}

Kayastha, Abhijeet K. ^{[1
]}

Yeole, Ravindra ^{[1
]}

Bhagwat, Sachin ^{[1
]}

Patel, Mahesh ^{[1
]}

机构：

[1] MIDC, Wockhardt Res Ctr, D-4, Aurangabad 431006, Maharashtra, India

来源：

MEDICINAL CHEMISTRY RESEARCH | 2024年 / 33卷 / 10期

关键词：

Biaryl oxazolidinones; antibiotics; gram-positive; MRSA; WCK; 3999; 4603;

D O I：

10.1007/s00044-024-03287-z

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Oxazolidinones are synthetic antibiotic class of compounds characterized by chemical structure, cyclic carbamate with 'S' configuration of substituent at C-5 position. The synthesis of oxazolidinones has gained increasing interest due to their unique mechanism of action that assures high antibiotic efficiency and low susceptibility to resistance mechanisms. Biaryl oxazolidinones are second-generation oxazolidinone (e.g. Tedizolid) having potency against multidrug-resistant (MDR) gram-positive pathogens including MRSA, VRE, penicillin-resistant S. pneumoniae and linezolid-resistant strains. The current manuscript covers structure activity based synthesis of 21 oxazolidinone analogs prepared through various chemical modifications. These novel biaryl oxazolidinones are prepared with the objective to increase spectrum of activity against multidrug-resistant Gram-positive bacteria. [GRAPHICS] .

引用

页码：1887 / 1896

页数：10

共 50 条

[21] GRAM-POSITIVE BACTERIAL INFECTIONS, TRANSMITTED FROM MOTHERS TO INFANTS
LEBOUAR, Y
MOZZICONACCI, P
ARCHIVES FRANCAISES DE PEDIATRIE, 1973, 30 (08): : 785 - 791
[22] CEFTAZIDIME THERAPY OF GRAM-POSITIVE BACTERIAL-INFECTIONS IN CHILDREN
SWENSON, E
GOOCH, WM
HIGBEE, MD
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 192 - 192
[23] TEICOPLANIN - A NEW AGENT FOR GRAM-POSITIVE BACTERIAL-INFECTIONS
EGGLESTON, M
OFOSU, J
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1988, 9 (05): : 209 - 211
[24] The Relationship of Opportunistic Gram-Positive Bacterial Biofilms and Nosocomial Infections
Hefni, Hamido M.
Mohamed, Tarek R.
Samaha, Hassan A. M.
Ahmed, Sameh R.
JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2015, 9 : 139 - 148
[25] New antimicrobial agents for the treatment of Gram-positive bacterial infections
Aksoy, D. Y.
Unal, S.
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (05) : 411 - 420
[26] Daptomycin therapy for invasive Gram-positive bacterial infections in children
Ardura, Monica I.
Mejias, Asuncion
Katz, Kathy S.
Revell, Paula
McCracken, George H., Jr.
Sanchez, Pablo J.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (12) : 1128 - 1132
[27] Gram-positive infections: lessons learnt and novel solutions
Finch, R.
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 3 - 8
[28] Telavancin: a novel lipoglycopeptide for serious Gram-positive infections
Laohavaleeson, Somvadee
Kuti, Joseph L.
Nicolau, David P.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (03) : 347 - 357
[29] Novel agents for the treatment of resistant Gram-positive infections
Woodford, N
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (02) : 117 - 137
[30] Novel Therapeutic Agents for Resistant Gram-Positive Infections
Manfredi, Roberto
Calza, Leonardo
CURRENT DRUG THERAPY, 2008, 3 (02) : 98 - 110

← 1 2 3 4 5 →